Ballentine Partners, LLC Abbott Laboratories Transaction History

Ballentine Partners, LLC

$5.81 Billion
Q4 2024

A detailed history of Ballentine Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ballentine Partners, LLC holds 43,538 shares of ABT stock, worth $5.44 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

43,538

Previous 37,939 14.76%

Holding current value

$5.44 Million

Previous $4.33 Million 13.85%

% of portfolio

0.08%

Previous 0.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	BUY	$111.93 - $119.39 $626,696 - $668,464	5,599 Added 14.76%	43,538 $4.92 Million
Q3 2024 Oct 23, 2024	BUY	$100.07 - $118.13 $368,057 - $434,482	3,678 Added 10.74%	37,939 $4.33 Million
Q2 2024 Aug 06, 2024	SELL	$100.73 - $112.44 $310,147 - $346,202	-3,079 Reduced 8.25%	34,261 $3.56 Million
Q1 2024 Apr 11, 2024	BUY	$109.52 - $120.96 $708,156 - $782,127	6,466 Added 20.94%	37,340 $4.24 Million
Q4 2023 Jan 23, 2024	SELL	$90.19 - $110.4 $259,837 - $318,062	-2,881 Reduced 8.54%	30,874 $3.4 Million
Q3 2023 Oct 19, 2023	BUY	$95.53 - $114.62 $117,884 - $141,441	1,234 Added 3.79%	33,755 $3.27 Million
Q2 2023 Jul 26, 2023	SELL	$100.78 - $112.29 $249,027 - $277,468	-2,471 Reduced 7.06%	32,521 $3.55 Million
Q1 2023 Apr 27, 2023	BUY	$96.86 - $114.01 $525,174 - $618,162	5,422 Added 18.34%	34,992 $3.54 Million
Q4 2022 Jan 27, 2023	BUY	$95.06 - $111.52 $476,916 - $559,495	5,017 Added 20.43%	29,570 $0
Q3 2022 Oct 26, 2022	BUY	$96.76 - $112.03 $118,531 - $137,236	1,225 Added 5.25%	24,553 $2.38 Million
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $102,988 - $124,480	1,009 Added 4.52%	23,328 $2.54 Million
Q1 2022 May 05, 2022	BUY	$114.02 - $139.04 $890,838 - $1.09 Million	7,813 Added 53.86%	22,319 $2.64 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $261,790 - $320,548	2,266 Added 18.51%	14,506 $2.04 Million
Q3 2021 Oct 27, 2021	BUY	$116.66 - $129.06 $74,079 - $81,953	635 Added 5.47%	12,240 $1.45 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $7,616 - $8,966	72 Added 0.62%	11,605 $1.35 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $21,876 - $25,774	-201 Reduced 1.71%	11,533 $1.38 Million
Q4 2020 Jan 25, 2021	SELL	$105.0 - $114.42 $214,725 - $233,988	-2,045 Reduced 14.84%	11,734 $1.28 Million
Q3 2020 Oct 22, 2020	BUY	$91.64 - $111.29 $18,602 - $22,591	203 Added 1.5%	13,779 $1.5 Million
Q2 2020 Jul 31, 2020	BUY	$76.57 - $98.0 $27,412 - $35,084	358 Added 2.71%	13,576 $1.24 Million
Q1 2020 Apr 23, 2020	BUY	$62.82 - $91.86 $49,564 - $72,477	789 Added 6.35%	13,218 $1.04 Million
Q4 2019 Jan 22, 2020	BUY	$78.51 - $87.4 $6,202 - $6,904	79 Added 0.64%	12,429 $1.08 Million
Q3 2019 Oct 21, 2019	SELL	$81.84 - $88.74 $10,557 - $11,447	-129 Reduced 1.03%	12,350 $1.03 Million
Q2 2019 Jul 25, 2019	BUY	$72.88 - $85.0 $238,536 - $278,205	3,273 Added 35.55%	12,479 $1.05 Million
Q1 2019 May 09, 2019	SELL	$66.22 - $80.06 $86,218 - $104,238	-1,302 Reduced 12.39%	9,206 $736,000
Q4 2018 Feb 04, 2019	BUY	$65.56 - $74.27 $71,919 - $81,474	1,097 Added 11.66%	10,508 $760,000
Q3 2018 Oct 30, 2018	BUY	$60.81 - $73.36 $7,053 - $8,509	116 Added 1.25%	9,411 $691,000
Q2 2018 Jul 19, 2018	BUY	$57.57 - $63.54 $25,100 - $27,703	436 Added 4.92%	9,295 $567,000
Q1 2018 Apr 26, 2018	SELL	$56.27 - $63.62 $3,601 - $4,071	-64 Reduced 0.72%	8,859 $531,000
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $106,125 - $113,618	-1,977 Reduced 18.14%	8,923 $509,000
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $523,854 - $584,676	10,900	10,900 $581,000

Others Institutions Holding ABT

# of Institutions

3,204

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $219B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Account

Ballentine Partners, LLC Abbott Laboratories Transaction History